Search clinical trials for: Pertuzumab (rhuMAb 2C4)
Total 5413 results
-
PfizerCompletedPharmacokinetics | Safety | ECGCanada, Spain, United States, Hungary, Poland, United Kingdom
-
Gilead SciencesCompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Low-Grade | Lymphoma, Small Lymphocytic | Leukemia, Prolymphocytic | NHL | CLL | Leukemia, Lymphocytic, Chronic | Lymphoma, Intermediate-Grade | Lymphoma, Large-Cell | Lymphoma, Mixed-Cell | Lymphoma, Small-Cell | Leukemia, B-Cell, Chronic | Leukemia... and other conditionsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myelogenous LeukemiaUnited States
-
RemeGen Co., Ltd.Recruiting
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline; Genentech, Inc.; Susan G. Komen Breast Cancer FoundationCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Hoffmann-La RocheTerminatedProstate CancerSpain, United Kingdom, France, Germany, Italy, Netherlands
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
Gilead SciencesUnknownLymphomaSwitzerland, United States, Italy, Sweden, Austria
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
University of Michigan Rogel Cancer CenterCompleted
-
Acute Leukemia French AssociationCompletedAcute Myeloid LeukemiaFrance
-
Medical College of WisconsinCompletedRelapsed Adult AMLUnited States
-
Gilead SciencesCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; Genentech, Inc.CompletedBreast CancerUnited States
-
Institut Català d'OncologiaFundación Sociedad Española de Oncologia Médica; Instituto de Salud Carlos III and other collaboratorsRecruitingNeoplasms | Breast Cancer | HER2-positive Breast CancerSpain
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingColorectal Neoplasms | Ovarian Neoplasms | Solid Tumor | Gallbladder Neoplasms | Prostatic Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Haematological Malignancy | Urinary Bladder Neoplasm | Skin Neoplasm | Salivary Gland NeoplasmUnited Kingdom
-
Hoffmann-La RocheCompletedBreast CancerCanada, Spain, France, United Kingdom, Italy
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.RecruitingHER2-positive Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisUnited States
-
Helsinki University Central HospitalActive, not recruiting
-
Genta IncorporatedCompleted
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
US Oncology ResearchGenentech, Inc.TerminatedBreast Neoplasms | Malignant Tumor of the BreastUnited States
-
University Hospital HeidelbergNational Center for Tumor Diseases, HeidelbergCompletedAcute Myeloid LeukemiaGermany
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerSpain, United States, Italy
-
University of OxfordBoehringer Ingelheim; Prostate Cancer UKActive, not recruiting
-
EirGenix, Inc.Sacura GmbHCompleted
-
Weill Medical College of Cornell UniversityPfizer; Jazz PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
Kimberly BlackwellTerminatedHER2 Positive Untreated Metastatic Breast Cancer | Asymptomatic or Low Symptomatic Brain Metastasis in Breast CancerUnited States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompleted
-
Shaare Zedek Medical CenterRecruiting
-
University of UlmCompleted
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
Qamar KhanRecruitingHER2-positive Breast CancerUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI); University of MichiganCompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
John QuigleyPfizer; AbbVieActive, not recruiting
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdCompletedSimilarity of Pharmacokinetics and SafetyChina
-
TakedaIntra-Cellular Therapies, Inc.TerminatedSchizophreniaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed